SGRY / Surgery Partners stock falls after public stock offering of $275 million, private placement of $225 mln

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepar more_horizontal

Surgery Partners (SGRY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined wit more_horizontal

Although the revenue and EPS for Surgery Partners (SGRY) give a sense of how its business performed in the quarter ended June 2023, it might be worth more_horizontal

Surgery Partners (SGRY) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to more_horizontal

BRENTWOOD, Tenn., July 19, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay more_horizontal

Surgery Partners comes with a set of attractive investment criteria. SGRY's economic characteristics, such as a consistent stream of 20% returns on ex more_horizontal

Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate more_horizontal

Surgery Partners, Inc. (NASDAQ:SGRY ) Q1 2023 Earnings Conference Call May 1, 2023 5:00 PM ET Company Participants Dave Doherty - Executive Vice Presi more_horizontal